Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management

AKYILDIZ A., Ismayilov R., Rustamova N., Tokatli M., KOÇ İ., AKIN S., et al.
Annals of Hematology , cilt.103, sa.3, ss.905-915, 2024 (SCI-Expanded) identifier identifier

SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research

GÜVEN D. C., Sahin T. K., AKIN S., Uckun F. M.
ONCOLOGIST , cilt.27, sa.11, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination

GÜVEN D. C., Sahin T. K., AKIN S., Uckun F. M.
ONCOLOGIST , cilt.27, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement

Akin S., Hosing C., Khouri I., Ahmed S., Alousi A., Fowler N., et al.
BLOOD ADVANCES , cilt.6, sa.7, ss.2267-2274, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement

Kupik O., Akin S., Tuncel M., Eren G., Türker A., Kars A., et al.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.41, sa.6, ss.540-549, 2020 (SCI-Expanded) identifier identifier identifier

Gemcitabine, Oxaliplatin and Paclitaxel (GemPOx ) in Patients with Relapsed or Refractory Germ Cell Tumors After High Dose Chemotherapy, A Retrospective Single-Center Experience

Acar R., Erturk I., Kiziloz H., Okcelik S., Yildiz B., Aykan M. B., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.4, ss.191-196, 2020 (SCI-Expanded) Creative Commons License identifier identifier

Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study

Sunar V., Korkmaz V., AKIN S., GÜVEN D. C., ARIK Z., Ates O., et al.
JOURNAL OF BUON , cilt.24, sa.6, ss.2327-2332, 2019 (SCI-Expanded) identifier identifier identifier

Association between androgen receptor status and prognosis in triple negative breast cancer

Sunar V., Dogan H. T., Sarici F., ATEŞ Ö., AKIN S., BAŞPINAR B., et al.
JOURNAL OF BUON , cilt.23, sa.5, ss.1325-1330, 2018 (SCI-Expanded) identifier identifier identifier

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma

AKIN S., DİZDAR Ö., KARAKAS Y., Turker A., Kars A.
CURRENT PROBLEMS IN CANCER , cilt.42, sa.3, ss.344-349, 2018 (SCI-Expanded) identifier identifier identifier

Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms

AKIN S., DİZDAR Ö., Hayran M.
ANNALS OF SURGICAL ONCOLOGY , cilt.24, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

Evaluation of complementary and alternative medicine trials registered in clinicaltrials.gov database

DİZDAR Ö., BİLGİN E., AKIN S., KILIÇKAP S., HAYRAN M.
JOURNAL OF BUON , cilt.22, sa.2, ss.530-534, 2017 (SCI-Expanded) identifier identifier identifier

Prediction of central lymph node metastasis in patients with thyroid papillary microcarcinoma

Akin S., Aksoy D. Y., AKIN S., KILIÇ M., Yetisir F., BAYRAKTAR M.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.6, ss.1723-1727, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer

Karatas F., Sahin S., Erdem G. U., ATEŞ Ö., BABACAN T., AKIN S., et al.
JOURNAL OF BUON , cilt.21, sa.4, ss.851-858, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients

Ozen M., Gunduz M., ATEŞ Ö., BABACAN T., SEVER A. R., AKIN S., et al.
JOURNAL OF BUON , cilt.21, sa.4, ss.799-808, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience

Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.
JOURNAL OF BUON , cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded) identifier identifier identifier

Interpretation of survival data: which graphical analysis is appropriate?

Dizdar O., AKIN S., HAYRAN M.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY , cilt.8, sa.4, ss.312, 2016 (SCI-Expanded) identifier identifier identifier

Analysis of the Adjuvant Hormone Therapy Randomized Trial

Karakas Y., AKIN S., DİZDAR Ö., AKSOY S.
JOURNAL OF CLINICAL ONCOLOGY , cilt.34, sa.17, ss.2070-2071, 2016 (SCI-Expanded) identifier identifier identifier

Leg cramps associated with tamoxifen use - possible mechanism and treatment recommendations

Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.
JOURNAL OF BUON , cilt.21, sa.2, ss.520, 2016 (SCI-Expanded) identifier identifier identifier

Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., et al.
JOURNAL OF BUON , cilt.21, sa.2, ss.375-381, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Vaccination Attitudes Among Patients with Cancer Receiving Chemotherapy

AKIN S., DİZDAR Ö., ÖZIŞIK L., TANRIOVER M., KAMISLI S., ERMAN M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.167-172, 2016 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Insomnia caused by aromatase inhibitors; a therapeutic challenge in patients with breast cancer

Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.
JOURNAL OF BUON , cilt.20, sa.6, ss.1640, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Does eribulin mesylate cause recurrent transient diplopia?

Karatas F., Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.
JOURNAL OF BUON , cilt.20, sa.5, ss.1379, 2015 (SCI-Expanded) identifier identifier identifier

Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer

BABACAN T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., Balakan O., et al.
TUMORI J , cilt.101, sa.4, ss.418-423, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Can aromatase inhibitors cause forgetfulness in women with breast cancer ?

Karatas F., AKIN S., BABACAN T., SEVER A. R., Altundag K.
JOURNAL OF BUON , cilt.20, sa.3, ss.935, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., et al.
JOURNAL OF BUON , cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab

ATEŞ Ö., Sunar V., BABACAN T., AKIN S., KERTMEN N., Altundag K.
JOURNAL OF BUON , cilt.20, sa.1, ss.349, 2015 (SCI-Expanded) identifier

Which sequence best protects the heart against trastuzumab and anthracycline toxicity An electron microscopy study in rats

KERTMEN N., AKSOY S., ÜNER A., ÖZGÜR Ö., keskin o., babacan t., et al.
Anticancer Research , 2015 (SCI-Expanded) identifier identifier

Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients

Hacioglu B., AKIN S., SEVER A. R., Altundag K.
FUTURE ONCOLOGY , cilt.11, sa.18, ss.2495-2497, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Comparison of three different induction regimens for nasopharyngeal cancer

KERTMEN N., AKSOY S., CENGİZ M., YAZICI G., KESKİN O., Babacan T., et al.
Asian Pacific Journal of Cancer Prevention , cilt.16, sa.1, ss.59-63, 2015 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

How long should we maintain anti-HER2 therapy for metastatic breast cancer patients with complete remission?

Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.
FUTURE ONCOLOGY , cilt.11, sa.20, ss.2799-2801, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Molecular subtypes in patients with inflammatory breast cancer; A single center experience

KERTMEN N., BABACAN T., Keskin O., Solak M., Sarici F., AKIN S., et al.
JOURNAL OF BUON , cilt.20, sa.1, ss.35-39, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Acute erythroid leukemia in a patient with chronic lymphocytic leukemia

GÜVEN D. C., BABACAN T., Sarici F., AKIN S., Altundag K., Turker A.
JOURNAL OF BUON , cilt.19, sa.4, ss.1127, 2014 (SCI-Expanded) identifier identifier identifier

Breast sarcoma: A rare malignancy

Gul G., BABACAN T., AKIN S., Sarici F., Altundag K.
JOURNAL OF BUON , cilt.19, sa.2, ss.577, 2014 (SCI-Expanded) identifier identifier identifier

A novel targeted therapy in breast cancer: Cyclin dependent kinase inhibitors

AKIN S., BABACAN T., Sarici F., Altundag K.
JOURNAL OF BUON , cilt.19, sa.1, ss.42-46, 2014 (SCI-Expanded) identifier identifier identifier

Nasopharyngeal sarcoidosis: a rare involvement

Akin S., Akin S., KARADAĞ Ö., KALYONCU U., Balci S., ÖZGEN MOCAN B.
RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.5, ss.1407-1409, 2012 (SCI-Expanded) identifier identifier identifier

Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.
MEDICAL ONCOLOGY , cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded) identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future

Srour S. A., AKIN S.
Journal of Immunotherapy and Precision Oncology , cilt.6, sa.1, ss.19-30, 2023 (Scopus) Creative Commons License identifier identifier

A Novel Tumor Marker for Anaplastic Lymphoma Kinase (+) Lymphoma: Beta-Human Chorionic Gonadotropin

Moral K., SEYHAN E., KUTLAY D. Y., AKIN S.
Journal of Oncological Science , cilt.9, sa.1, ss.46-49, 2023 (Scopus) Creative Commons License identifier identifier

Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review

YILDIRIM H. Ç., AKYILDIZ A., Ismayilov R., Demirok N., BENLİ B. S., Guven D. C., et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY , cilt.15, sa.4, ss.307-310, 2022 (ESCI) identifier identifier

Farklı Trombositopeni Sebeplerinin Klinik ve Laboratuvar Bulguları

AKIN S., AKIN Ş., Karaağaç A. T., HAZNEDAROĞLU İ. C.
Journal of Contemporary Medicine , cilt.7, sa.4, ss.316-322, 2017 (Hakemli Dergi) Creative Commons License

Symptomatic Adrenal Insufficiency due to Bilateral Adrenal Non-Hodgkin’s Lymphoma

AKIN Ş., Akın S., TUNCEL M., ERSÖZ G. N.
Turkish Journal of Endocrinology and Metabolism , cilt.20, ss.108-110, 2016 (Scopus)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

The Role of FDG PET/CT Detecting Bone Marrow Involvement in Non-Hodgkin's Lymphoma Patients

KUPIK O., Akin S., TUNCEL M., TÜRKER A., Kars A., Erbas B.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45 identifier

Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma

ATEŞ Ö., AKSOY S., YETER H. H., Akın S., KERTMEN N., DİZDAR Ö., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016

The impact of the total size of lesions in multifocal multicentric breast cancer on survival

Karakaş Y., DİZDAR Ö., Akın S., ATEŞ Ö., ŞENDUR M. A. N., AKSOY S., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016 Sürdürülebilir Kalkınma

The impact of the total size of lesions in multifocal/multicentric breast cancer on survival.

Karakas Y., Dizdar O., Akin S., Ates O., Sendur M. A. N., Aksoy S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 Sürdürülebilir Kalkınma identifier

Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

Ateş Ö., Babacan T., SARICI F., KERTMEN N., CENOLİ A., Akın S., et al.
ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015 Sürdürülebilir Kalkınma identifier identifier

Signet ring cell carcinoma of breast: Single center experience.

AKIN S., DIKER O., KERTMEN N., ATEŞ Ö., DİZDAR Ö., YALÇIN Ş., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 identifier

Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.

Diker O., Babacan T., Buyukhatipoglu H., Kertmen N., Balakan O., Sever A. R., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma identifier

Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer.

Altundag K., Babacan T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma identifier

Which sequence prevents the heart from trastuzumab and anthracycline toxicity: Electron microscopy study in rats

Aksoy S., Kertmen N., ÜNER A., Sargon M., Ozkayar O., Keskin O., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 identifier

Comparison of three different induction regimen in nasopharyngeal cancer: CF versus DC versus DCF.

Kertmen N., Aksoy S., Cengiz M., Yazici G., Keskin O., Babacan T., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 Sürdürülebilir Kalkınma identifier

Is there any correlation between molecular subtypes and blood groups in breast cancer?

Kucukoztas N., Oguz A., Babacan T., Dizdar O., Rahatli S., Sarici S. F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 Sürdürülebilir Kalkınma identifier

Metrikler

Yayın

53

Atıf (WoS)

104

H-İndeks (WoS)

6

Atıf (Scopus)

92

H-İndeks (Scopus)

6

Proje

3

Açık Erişim

10
BM Sürdürülebilir Kalkınma Amaçları